Journal of Natural Medicines

, Volume 65, Issue 1, pp 50–56

Ginkgo biloba extract enhances glucose tolerance in hyperinsulinism-induced hepatic cells

Authors

  • Lei Zhou
    • Key Laboratory of Agricultural Animal Genetics, Breeding and Reproduction of the Ministry of EducationCollege of Life Science and Technology, Huazhong Agricultural University
  • Qingjie Meng
    • Key Laboratory of Agricultural Animal Genetics, Breeding and Reproduction of the Ministry of EducationCollege of Life Science and Technology, Huazhong Agricultural University
  • Tao Qian
    • Key Laboratory of Agricultural Animal Genetics, Breeding and Reproduction of the Ministry of EducationCollege of Life Science and Technology, Huazhong Agricultural University
    • Key Laboratory of Agricultural Animal Genetics, Breeding and Reproduction of the Ministry of EducationCollege of Life Science and Technology, Huazhong Agricultural University
Original Paper

DOI: 10.1007/s11418-010-0456-z

Cite this article as:
Zhou, L., Meng, Q., Qian, T. et al. J Nat Med (2011) 65: 50. doi:10.1007/s11418-010-0456-z

Abstract

Ginkgo biloba, an herbal medication, is capable of lowering glucose, fat, and lipid peroxide in diabetic patients. In the current study, we tested the hypothesis that Ginkgo biloba extract (GBE) prevented hyperinsulinism-induced glucose intolerance in hepatocytes. We investigated the effects of GBE on glucose consumption, glucokinase activity, and mRNA levels of key genes in glucose metabolism and the insulin signaling pathway. To better show its efficacy, we included a control group that was treated with rosiglitazone, a type of thiazolidinedione (TZD). The data indicated that GBE repressed glucose uptake under normal conditions, while it dramatically improved glucose tolerance under insulin-resistant conditions. Furthermore, after analyzing gene expression, we suggest that GBE chiefly exerts its effects by stimulating IRS-2 transcription. It should be noted that, unlike rosiglitazone, GBE did not stimulate excessive glucose uptake as it improved glucose tolerance. It is said that GBE treatment could avoid drug-induced obesity. Our data suggest that GBE has the potential to prevent insulin resistance and is a promising anti-diabetic drug.

Keywords

HerbThiazolidinedioneDiabetesInsulin resistanceHepatocytes

Abbreviations

GBE

Ginkgo biloba extract

G6Pase

Glucose-6-phosphatase

IRS

Insulin receptor substrate

GLUT

Glucose transporter

PPAR

Peroxisome proliferator-activated receptor

SREBP

Sterol regulatory element-binding protein

TZD

Thiazolidinedione

Copyright information

© The Japanese Society of Pharmacognosy and Springer 2010